CARR Biosystems Cell & Gene Tech Expo April 2026: Cell Therapy

Effective cell handling is a cornerstone of successful bioprocessing, yet it remains a persistent source of variability and unwanted aggregation. Maintaining cell health during critical stages—such as harvest, media exchange, and concentration—requires a delicate balance between processing speed and physical protection. Standard manual methods often fail to scale, while many automated alternatives subject sensitive cells like iPSCs, MSCs, and NK cells to damaging shear forces.

Transitioning to low-shear, automated centrifugation allows for precise control over flow rates and G-force, preserving delicate morphologies and pluripotency regardless of scale. Case studies demonstrate that consistent, recipe-driven handling can achieve over 95% recovery and 98% viability, significantly outperforming traditional spinning membrane filtration and gravity sedimentation. By integrating sterile, single-use modules with scalable hardware, manufacturers can ensure reproducible outcomes from benchtop research to commercial production. This presentation explores how optimized cell handling mitigates genetic instability and streamlines downstream processing.

About CARR Biosciences

With over three decades of pioneering versatile stainless steel and single-use separation systems, CARR Biosystems delivers high-performance, fully scalable bioprocessing solutions to accelerate process development. We help scientists and engineers produce vital biologics in emerging and established markets, including cell and gene therapy, vaccine development, microbial fermentation, and cellular agriculture